SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001683168-20-002022
Filing Date
2020-06-22
Accepted
2020-06-22 14:13:06
Documents
4
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 canna_10ka1-2019.htm 10-K/A 590158
2 CERTIFICATION canna_ex3101.htm EX-31.1 9804
3 CERTIFICATION canna_ex3102.htm EX-31.2 9568
4 CERTIFICATION canna_ex3200.htm EX-32 4260
  Complete submission text file 0001683168-20-002022.txt   615096
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-27055 | Film No.: 20978181
SIC: 2834 Pharmaceutical Preparations